These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6208416

  • 1. Overview and other metabolic issues and concerns in management of mild hypertension.
    Chobanian AV.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S483-6. PubMed ID: 6208416
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipid metabolism: implications of alpha 1-blockade.
    Rosenthal J.
    J Clin Pharmacol; 1993 Sep; 33(9):883-7. PubMed ID: 7901243
    [Abstract] [Full Text] [Related]

  • 4. [Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses].
    Rouffy J.
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():43-6. PubMed ID: 2887148
    [Abstract] [Full Text] [Related]

  • 5. [Cardiovascular diseases and clinical laboratory examination. (4). Metabolic abnormalities in hypertension and their modification by antihypertensive drugs].
    Ebihara A.
    Rinsho Byori; 1983 Oct; 31(10):1073-7. PubMed ID: 6143841
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE Study.
    Aranda P, Tamargo J, Aranda FJ, Luque M, López-Garcia-Franco A.
    Blood Press Suppl; 1997 Oct; 1():11-6. PubMed ID: 9285102
    [Abstract] [Full Text] [Related]

  • 8. Prazosin: a review of clinical experience in hypertension.
    Packard RS.
    Ther Umsch; 1981 Oct; 38 Suppl():28-32. PubMed ID: 6122285
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Orthostatic hypotension in patients with antihypertensive combination therapy].
    Holzgreve H.
    MMW Fortschr Med; 2009 Jun 25; 151(26-29):29-30. PubMed ID: 19739543
    [No Abstract] [Full Text] [Related]

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan 25; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 12. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B, Brilla C, Kruse T, Noll B, Bethge C.
    Herz; 1995 Dec 25; 20(6):370-89. PubMed ID: 8582697
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive treatment and its implications on lipoprotein metabolism of patients in care by a hypertension and diabetes program in Brazil.
    Martins RD, Alves Rde S, Silva GG, Martins N, Vasconcelos S, Assreuy A, Martins A, Goretti Queiroz M.
    Acta Med Port; 2008 Dec 25; 21(6):567-74. PubMed ID: 19331790
    [Abstract] [Full Text] [Related]

  • 14. Current issues in the management of hypertension.
    Sheaffer SL, Fye DL.
    Clin Pharm; 1984 Dec 25; 3(1):40-8. PubMed ID: 6365415
    [Abstract] [Full Text] [Related]

  • 15. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Dec 25; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive drug therapy and coronary heart disease risk.
    Schoenberger JA.
    J Fam Pract; 1993 Jan 25; 36(1):70-3, 77-84. PubMed ID: 8419507
    [Abstract] [Full Text] [Related]

  • 17. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 Jan 25; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 18. [Rational hypertension treatment].
    Canova CR.
    Schweiz Med Wochenschr; 1996 Aug 17; 126(33):1394-9. PubMed ID: 8830397
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 17; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 20. Doxazosin in the current treatment of hypertension.
    Wykretowicz A, Guzik P, Wysocki H.
    Expert Opin Pharmacother; 2008 Mar 17; 9(4):625-33. PubMed ID: 18312163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.